Share this article Share this article ResearchAndMarkets.com's offering. The global aortic valve market is predicted to attain a revenue of $29,146.9 million by 2030, advancing at a 13.2% CAGR during the forecast period (2020-2030) A key factor leading to the growth of the market is the increasing prevalence of aortic regurgitation and aortic stenosis. Rheumatic heart disease (RHD) is the most common cause of aortic regurgitation. When procedure is taken into consideration, the aortic valve market is divided into open surgery and minimally invasive surgery (MIS), between which, the MIS division held the major value share of the market in 2019. The division is further predicted to register the higher CAGR in the years to come. Minimally invasive aortic valve replacement is primarily done by utilizing the transfemoral approach that is allowed by the large diameter of the artery, thereby letting the catheter pass easily through it.